IL22 and neoplasm: In non-small cell lung carcinoma (NSCLC), overexpression of IL-22 protected lung cancer cell lines from apoptosis, while downregulation of IL-22 significantly inhibited the human tumor cell growth in BALB/c nude mice [13].